[Ip-health] IFPMA press release on Alicia Greenidge

Mon Jun 2 11:48:07 2008

Jamie and all,

  I except your evaluation of Ms. Greenidge from the perspective
in which it is given.  I however remain concerned that she comes
from USTR, which has been far more friendly to US drug manufacturers
than it has been to consumers.  USTR has over the past 10+ years
taken a more interested stance in favor of Drug manufacturers which
in the long run have not favored American drug consumers, as the
cost of drugs long sense in the marketplace have escalated over
200% in the past 10 years.  That's simply not justified or even
close to reasonable.

-----Original Message-----
>From: James Love <james.love@keionline.org>
>Sent: May 31, 2008 5:02 AM
>To: Ip-health <ip-health@lists.essential.org>
>Subject: [Ip-health] IFPMA press release on Alicia Greenidge
>
>Below is the official release from the IFPMA on Alicia Greenidge.  As I
>noted yesterday, I think Alicia is a good choice for the IFPMA.
>
>Compared to some other possibilities for a position like this, she is
>not a hardliner or ideologue.  She is smart and tough, and humor, charm,
>and warmth are among her many assets.
>
>In terms of the global health agenda, she can play a particularly
>important role if she can find ways to constructively engage on new
>approaches to rewarding drug developers.
>
>A concern is that Ms Greenidge has played an important role in opposing
>nearly every i+a initiative that we have supported in the past decade,
>on behalf of the US government, working closely with the IFPMA and its
>members.  This includes the use of diplomatic power and bullying many
>country delegations and US agencies, to advance the pharmaceutical
>industry agenda. She knows as well as anyone the instruments of power
>and leverage used by the US government in trade negotiations, and will
>be a position to  press US negotiators hard.
>
>  Jamie
>
>----
>IFPMA Appoints Alicia Greenidge as New Director General
>
>Geneva, 30 May 2008 - The International Federation of Pharmaceutical Manuf=
acturers & Associations (IFPMA) is pleased to announce the appointment of A=
licia Greenidge as its new Director General. She will take office on 2 June=
 2008 and will succeed Dr. Harvey Bale, who is retiring after almost eleven=
 years in the position.
>
>Mr. Fred Hassan, President of the IFPMA and Chairman and CEO of Schering-P=
lough, said: "Ms. Greenidge has extensive experience working with the Genev=
a-based intergovernmental organizations, as well as substantive knowledge o=
f many issues of concern to the IFPMA. This experience, combined with a pra=
ctical approach and keen mind, will equip her well for this challenging rol=
e. I am very pleased with her appointment to lead IFPMA."
>
>Ms. Greenidge comes to the IFPMA with more than fifteen years experience i=
n bilateral and multilateral negotiations with governments in the Americas,=
 Africa, Asia, Pacific, Middle East, and Europe, working largely for the Of=
fice of the United States Trade Representative (USTR), both in Washington a=
nd in Geneva. In Geneva for nearly ten years, Ms. Greenidge served for a pe=
riod as Acting Deputy Chief of Mission and, for the last eight years, as As=
sistant Deputy Chief of Mission and Senior Counsel.
>
>Ms. Greenidge has gained a reputation as a strong and effective negotiator=
, but also as a bridge and coalition builder. She has kept channels of comm=
unication open and contributed to many settlements and decisions before the=
 World Trade Organization, notably the Public Health Declaration leading up=
 to and at Doha, Qatar in 2001 and subsequent agreements with regard to loc=
al pharmaceutical manufacturing capacity in developing countries, especiall=
y Africa. She has participated in deliberations concerning questions on the=
 relationship of the Trade Related Intellectual Property Rights agreement (=
TRIPS), traditional knowledge and the Convention on Biodiversity and led in=
 negotiated agreements on Least Developed Country matters under TRIPS.
>
>Since 1998, she also has interacted with, and advised on issues before, ot=
her inter-governmental organizations, such as WHO (including IGWG issues an=
d the IGM on virus sharing and access to vaccines), UNAIDS, WIPO, UNCTAD an=
d others. In addition, she has engaged constructively with several non-gove=
rnmental organizations in Geneva.
>
>During her government service, she has interacted with industries and asso=
ciations representing various sectors, including pharmaceuticals and her ac=
tivities spanned across other subjects as well, such as trade remedies, dis=
pute settlement, textiles, electronic commerce, investment measures, develo=
pment assistance, aspects of the cotton issue, bananas and services trade.
>
>Ms. Greenidge has a Juris Doctorate from Boston College, a Master's degree=
 in Public International Law & International Development Economics from the=
 American University, and a Bachelor's degree in International Relations an=
d Sociology from C.W. Post College/LIU in the United States.
>
>
>
>_______________________________________________
>Ip-health mailing list
>Ip-health@lists.essential.org
>http://lists.essential.org/mailman/listinfo/ip-health

Regards,

Spokesman for INEGroup LLA. - (Over 281k members/stakeholders strong!)
"Obedience of the law is the greatest freedom" -
   Abraham Lincoln

"Credit should go with the performance of duty and not with what is
very often the accident of glory" - Theodore Roosevelt

"If the probability be called P; the injury, L; and the burden, B;
liability depends upon whether B is less than L multiplied by
P: i.e., whether B is less than PL."
United States v. Carroll Towing  (159 F.2d 169 [2d Cir. 1947]
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Updated 1/26/04
CSO/DIR. Internet Network Eng. SR. Eng. Network data security IDNS.
div. of Information Network Eng.  INEG. INC.
ABA member in good standing member ID 01257402 E-Mail
jwkckid1@ix.netcom.com
My Phone: 214-244-4827